Learn More
Juan Carlos Plana, MD, FASE, Chair, Maurizio Galderisi, MD, FESC, Co-Chair, Ana Barac, MD, PhD, Michael S. Ewer, MD, JD, Bonnie Ky, MD, FASE, Marielle Scherrer-Crosbie, MD, PhD, FASE, Javier Ganame,(More)
Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and(More)
OBJECTIVES The aim of this study was to identify the best echocardiographic method for sequential quantification of left ventricular (LV) ejection fraction (EF) and volumes in patients undergoing(More)
The literature exploring the utility of advanced echocardiographic techniques (such as deformation imaging) in the diagnosis and prognostication of patients receiving potentially cardiotoxic cancer(More)